Skip to main content

Blue Biofuels, Inc.

corporate_fare Company Profile

Blue Biofuels, Inc.

BIOF·OTC·Industrial Applications And Services·CIK 0001549145

Blue Biofuels, Inc. is a technology company focused on emerging technologies in renewable energy, biofuels, and lignin since December 2013. The company's core offering is its Cellulose-to-Sugar (CTS) process, a continuous mechanical/chemical method for breaking down cellulosic material into biofuels. This process can utilize various cellulosic materials, including grasses and agricultural waste, and allows for precise control to optimize reaction parameters and efficiency. The initial CTS reactor technology was invented by CEO Ben Slager in early 2018, leading to a process patent application. This patent (U.S. Patent No. 10,994,255) was granted in the United States in 2021 and subsequently in Japan, Australia, Russia, and El Salvador. Patent applications are pending in other major jurisdictions, including the European Patent Organization, Brazil, China, and the African Regional Intellectual Property Organization. The company has also secured two additional U.S. patents (U.S. Patent No. 11,484,858B2), with applications filed in the same international jurisdictions, and has 3 other U.S. patent applications currently pending. The company underwent a voluntary Chapter 11 financial restructuring, filing on October 22, 2018, and exiting on September 18, 2019, with the bankruptcy case closing on October 25, 2019.

Blue Biofuels, Inc. (OTC:BIOF) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 5 items for BIOF at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-13, rated 8/10. Across its 5 most recent items scored 7 or higher, the top rating is 9/10, with 4 rated 8 or above. Recent SEC coverage for BIOF spans 10-Q, 8-K, 10-K.

Recent high-impact activity:

  • Blue Biofuels Q3: Cash Down to $6,473, Going-Concern Warning Reiterated
  • Blue Biofuels Q2 2026: Cash Drops to $22K, Going Concern Warning Reiterated, Massive Option Modifications
  • Blue Biofuels Changes Auditor Due to Merger, New Firm Takes Over
  • Blue Biofuels Reports Critically Low Cash, Worsening Losses, and Reiterates Going Concern Warning Amidst Significant Funding Gap
  • Annual Report Highlights Going Concern, $60M Accumulated Deficit, and Critical $90M Financing Need

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
-$2.87M
Diluted EPS
-$0.01
Op. Cash Flow
-$845K
Free Cash Flow
-$913.9K
Operating Income
-$3.72M
Cash & Equivalents
$65.2K
Debt / Equity
0.00×
Shares Outstanding
317.87M sh
Source: 10-K · filed 2026-03-19 · accession 0001493152-26-011555

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 281,764 shares in BIOF as of the October 30, 2026 settlement, a 145.7% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 36.6% of BIOF volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)281,764 shares as of October 30, 2026
Change vs prior period▲ 145.7%
Days to cover1.00 at avg daily volume of 1,061,286
Daily short volume (FINRA facilities)36.6% of 63,106 shares on November 20, 2026
5-day average short volume48.2%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with B →
$0.109
52-week range · as of 2026-11-13 $0.0661 – $0.1999
Market cap
$33.42M
Volume
63.1K (0.2× avg)
3-mo avg 330.5K
Live data · 2026-11-21 20:04 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed BIOF - Latest Insights

BIOF
Nov 13, 2026, 6:20 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.115
Real-time Price: $0.109 info
Change: -$0.0060 (-5%) info
Market Cap: $33.415M info
BIOF
Aug 10, 2026, 6:05 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.108855
Real-time Price: $0.109 info
Change: +$0.000145 (+0.13%) info
Market Cap: $33.415M info
BIOF
Jun 08, 2026, 9:54 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.120
Real-time Price: $0.109 info
Change: -$0.011 (-9%) info
Market Cap: $33.415M info
BIOF
May 04, 2026, 12:06 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.159
Real-time Price: $0.109 info
Change: -$0.050 (-31%) info
Market Cap: $33.415M info
BIOF
Mar 19, 2026, 11:17 AM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.16005
Real-time Price: $0.109 info
Change: -$0.05105 (-32%) info
Market Cap: $33.415M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets